We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Mixture of weight problems remedy tirzepatide and menopause hormone remedy fuels weight reduction
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Mixture of weight problems remedy tirzepatide and menopause hormone remedy fuels weight reduction
Mixture of weight problems remedy tirzepatide and menopause hormone remedy fuels weight reduction
Health

Mixture of weight problems remedy tirzepatide and menopause hormone remedy fuels weight reduction

Last updated: July 12, 2025 8:16 pm
Editorial Board Published July 12, 2025
Share
SHARE

Credit score: Unsplash/CC0 Public Area

Utilizing tirzepatide and menopause hormone remedy on the similar time results in elevated weight reduction in postmenopausal ladies with obese or weight problems in contrast to make use of of tirzepatide remedy alone, in keeping with a research being offered Saturday at ENDO 2025, the Endocrine Society’s annual assembly in San Francisco, Calif.

“These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women,” stated Regina Castaneda, M.D., analysis fellow for the Division of Endocrinology on the Mayo Clinic in Jacksonville, Fla.

“Previous studies of the medication semaglutide found similar results. Achieving these outcomes with a second obesity medication may indicate a broader efficacy trend for pairing these two classes of medications.”

Menopause-related hormonal modifications usually end in elevated belly fats, decreased muscle mass and altered power expenditure, which results in weight acquire and places tens of millions of ladies in danger for creating coronary heart illness and different critical well being points.

To substantiate the speculation that concurrent menopause hormone remedy enhances the effectiveness of tirzepatide for weight reduction in postmenopausal ladies, researchers performed a real-world research utilizing the digital medical data of 120 postmenopausal ladies over a median length of 18 months. The research included two cohorts: 40 ladies utilizing menopause hormone remedy concurrently with tirzepatide and 80 ladies utilizing tirzepatide alone.

The outcomes confirmed superior whole physique weight reduction proportion for ladies utilizing tirzepatide plus menopause hormone remedy (17%) in comparison with these utilizing tirzepatide alone (14%). As well as, the next proportion of menopause hormone remedy customers (45%) additionally achieved no less than 20% whole physique weight reduction, in comparison with 18% of menopause hormone remedy non-users.

“The information garnered through this new study provides important insights to develop more effective and personalized weight management interventions to reduce a postmenopausal woman’s risk of overweight and obesity-related health complications,” stated Maria Daniela Hurtado Andrade, M.D., Ph.D., assistant professor of drugs and advisor for the Division of Endocrinology on the Mayo Clinic.

“This study underscores the urgent need for further research to better understand how obesity medications and menopause hormone therapy work together. Gaining this knowledge could greatly improve the health and well-being of millions of postmenopausal women. It also points to the need for better strategies to make these treatments more accessible and available to those who need them.”

Offered by
The Endocrine Society

Quotation:
Mixture of weight problems remedy tirzepatide and menopause hormone remedy fuels weight reduction (2025, July 12)
retrieved 12 July 2025
from https://medicalxpress.com/information/2025-07-combination-obesity-medication-tirzepatide-menopause.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Hundreds of thousands of yard swimming pools recalled after drowning deaths of 9 kids

Q&A: Researchers focus on new insights on neurodegeneration from AI and mind imaging

‘Weekend warriors’ with diabetes have a 33% decrease danger of cardiovascular mortality, examine exhibits

Examine hyperlinks ‘endlessly chemical compounds’ to elevated threat of kind 2 diabetes

Regardless of self-perceived sensitivities, research finds gluten and wheat secure for many individuals with IBS

TAGGED:combinationFuelshormonelossmedicationMenopauseObesitytherapyTirzepatideWeight
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Endeavor sells arts group Frieze to Ari Emanuel
Entertainment

Endeavor sells arts group Frieze to Ari Emanuel

Editorial Board May 1, 2025
Falls prevention: Name for evaluation of antidepressant remedy use in aged care houses
A Decaying Art Gem Signifying Venezuela’s Divisions Could Now Help It Heal
The best way to Create Your First NFT: A Newbie-Pleasant Information
Dum Dums lollipops stands by vivid dyes, regardless of RFK Jr.’s push

You Might Also Like

Anti-obesity drugs related to weight rebound post-treatment
Health

Anti-obesity drugs related to weight rebound post-treatment

July 22, 2025
Close to tripling in US reported lidocaine native anesthetic poisonings/deaths over previous decade, evaluation reveals
Health

Close to tripling in US reported lidocaine native anesthetic poisonings/deaths over previous decade, evaluation reveals

July 22, 2025
Coronary heart failure life expectancy is six months shorter in most disadvantaged areas
Health

Coronary heart failure life expectancy is six months shorter in most disadvantaged areas

July 21, 2025
GLP-1 receptor agonists might enhance outcomes in idiopathic intracranial hypertension
Health

GLP-1 receptor agonists might enhance outcomes in idiopathic intracranial hypertension

July 21, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?